Growing up on a farm is associated with an asthma-protective effect, but the mechanisms underlying this effect are largely unknown. In the Protection against Allergy: Study in Rural Environments (PASTURE) birth cohort, we modeled maturation using 16S rRNA sequence data of the human gut microbiome in infants from 2 to 12 months of age. The estimated microbiome age (EMA) in 12-month-old infants was associated with previous farm exposure (β = 0.27 (0.12–0.43), P = 0.001, n = 618) and reduced risk of asthma at school age (odds ratio (OR) = 0.72 (0.56–0.93), P = 0.011). EMA mediated the protective farm effect by 19%. In a nested case–control sample (n = 138), we found inverse associations of asthma with the measured level of fecal butyrate (OR = 0.28 (0.09–0.91), P = 0.034), bacterial taxa that predict butyrate production (OR = 0.38 (0.17–0.84), P = 0.017) and the relative abundance of the gene encoding butyryl–coenzyme A (CoA):acetate–CoA-transferase, a major enzyme in butyrate metabolism (OR = 0.43 (0.19–0.97), P = 0.042). The gut microbiome may contribute to asthma protection through metabolites, supporting the concept of a gut–lung axis in humans.
This is a preview of subscription content, access via your institution
Open Access articles citing this article.
Microbiome Open Access 24 December 2022
Nature Communications Open Access 15 November 2022
Donor age and body weight determine the effects of fecal microbiota transplantation on growth performance, and fecal microbiota development in recipient pigs
Journal of Animal Science and Biotechnology Open Access 11 April 2022
Subscribe to Nature+
Get immediate online access to Nature and 55 other Nature journal
Subscribe to Journal
Get full journal access for 1 year
only $6.58 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
Taxonomy was assigned using the Greengenes database (http://greengenes.lbl.gov) for 16S rRNA sequences and the UNITE dynamic database (https://unite.ut.ee/) for ITS sequences. All 16S rRNA and ITS sequences are deposited in the Supplementary Information without metadata. PASTURE is an ongoing birth cohort with fieldwork still being executed. As long as the study is not anonymized, European data protection legislation prohibits sharing of individual data, even when pseudonymized. Upon request, the authors will share aggregate data that do not allow identification of individuals.
Barker, D. J. The fetal and infant origins of adult disease. BMJ301, 1111 (1990).
Tamburini, S., Shen, N., Wu, H. C. & Clemente, J. C. The microbiome in early life: implications for health outcomes. Nat. Med.22, 713–722 (2016).
de Steenhuijsen Piters, W. A. et al. Nasopharyngeal microbiota, host transcriptome, and disease severity in children with respiratory syncytial virus infection. Am. J. Respir. Crit. Care Med.194, 1104–1115 (2016).
Chung, H. et al. Gut immune maturation depends on colonization with a host-specific microbiota. Cell149, 1578–1593 (2012).
Ege, M. J. The hygiene hypothesis in the age of the microbiome. Ann. Am. Thorac. Soc.14, S348–S353 (2017).
Ege, M. J. et al. Exposure to environmental microorganisms and childhood asthma. N. Engl. J. Med.364, 701–709 (2011).
Stein, M. M. et al. Innate immunity and asthma risk in Amish and Hutterite farm children. N. Engl. J. Med.375, 411–421 (2016).
Illi, S. et al. Protection from childhood asthma and allergy in Alpine farm environments—the GABRIEL Advanced Studies. J. Allergy Clin. Immunol. 129, 1470–1477 (2012).
Birzele, L. T. et al. Environmental and mucosal microbiota and their role in childhood asthma. Allergy72, 109–119 (2017).
Depner, M. et al. Bacterial microbiota of the upper respiratory tract and childhood asthma. J. Allergy Clin. Immunol. 139, 826–834 (2017).
Trompette, A. et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat. Med.20, 159–166 (2014).
Stewart, C. J. et al. Temporal development of the gut microbiome in early childhood from the TEDDY study. Nature562, 583–588 (2018).
Yassour, M. et al. Natural history of the infant gut microbiome and impact of antibiotic treatment on bacterial strain diversity and stability. Sci. Transl. Med.8, 343ra381 (2016).
Depner, M. et al. Clinical and epidemiologic phenotypes of childhood asthma. Am. J. Respir. Crit. Care Med.189, 129–138 (2014).
Kumbhare, S. V., Patangia, D. V., Patil, R. H., Shouche, Y. S. & Patil, N. P. Factors influencing the gut microbiome in children: from infancy to childhood. J. Biosci.44, 49 (2019).
Backhed, F. et al. Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host Microbe17, 690–703 (2015).
Bokulich, N. A. et al. Antibiotics, birth mode, and diet shape microbiome maturation during early life. Sci. Transl. Med.8, 343ra382 (2016).
Borewicz, K. et al. The effect of prebiotic fortified infant formulas on microbiota composition and dynamics in early life. Sci. Rep.9, 2434 (2019).
Abrahamsson, T. R. et al. Low gut microbiota diversity in early infancy precedes asthma at school age. Clin. Exp. Allergy44, 842–850 (2014).
Arrieta, M. C. et al. Early infancy microbial and metabolic alterations affect risk of childhood asthma. Sci. Transl. Med.7, 307ra152 (2015).
Fujimura, K. E. et al. Neonatal gut microbiota associates with childhood multisensitized atopy and T cell differentiation. Nat. Med.22, 1187–1191 (2016).
Galazzo, G. et al. Development of the microbiota and associations with birth mode, diet, and atopic disorders in a longitudinal analysis of stool samples, collected from infancy through early childhood. Gastroenterology158, 1584–1596 (2020).
Ege, M. J. et al. Environmental bacteria and childhood asthma. Allergy67, 1565–1571 (2012).
Gardiner, B. J. et al. Clinical and microbiological characteristics of Eggerthella lenta bacteremia. J. Clin. Microbiol.53, 626–635 (2015).
Wang, Q. et al. A metagenome-wide association study of gut microbiota in asthma in UK adults. BMC Microbiol.18, 114 (2018).
Stiemsma, L. T. et al. Shifts in Lachnospira and Clostridium sp. in the 3-month stool microbiome are associated with preschool age asthma. Clin. Sci.130, 2199–2207 (2016).
Stokholm, J. et al. Maturation of the gut microbiome and risk of asthma in childhood. Nat. Commun.9, 141 (2018).
Simonyte Sjodin, K. et al. Temporal and long-term gut microbiota variation in allergic disease: a prospective study from infancy to school age. Allergy74, 176–185 (2019).
Yang, B. et al. A meta-analysis of the effects of probiotics and synbiotics in children with acute diarrhea. Medicine98, e16618 (2019).
Derrien, M., Alvarez, A. S. & de Vos, W. M. The gut microbiota in the first decade of life. Trends Microbiol.27, 997–1010 (2019).
Theiler, A. et al. Butyrate ameliorates allergic airway inflammation by limiting eosinophil trafficking and survival. J. Allergy Clin. Immunol.144, 764–776 (2019).
Roduit, C. et al. High levels of butyrate and propionate in early life are associated with protection against atopy. Allergy74, 799–809 (2019).
Louis, P., Young, P., Holtrop, G. & Flint, H. J. Diversity of human colonic butyrate-producing bacteria revealed by analysis of the butyryl–CoA:acetate CoA-transferase gene. Environ. Microbiol.12, 304–314 (2010).
Riviere, A., Selak, M., Lantin, D., Leroy, F. & De Vuyst, L. Bifidobacteria and butyrate-producing colon bacteria: importance and strategies for their stimulation in the human gut. Front. Microbiol.7, 979 (2016).
Reichardt, N. et al. Specific substrate-driven changes in human faecal microbiota composition contrast with functional redundancy in short-chain fatty acid production. ISME J.12, 610–622 (2018).
Reichardt, N. et al. Phylogenetic distribution of three pathways for propionate production within the human gut microbiota. ISME J.8, 1323–1335 (2014).
Tamanai-Shacoori, Z. et al. Roseburia spp.: a marker of health? Future Microbiol. 12, 157–170 (2017).
Frati, F. et al. The role of the microbiome in asthma: the gut–lung axis. Int. J. Mol. Sci.20, 123 (2018).
Marsland, B. J., Trompette, A. & Gollwitzer, E. S. The gut–lung axis in respiratory disease. Ann. Am. Thorac. Soc.12(Suppl. 2), S150–S156 (2015).
Singh, P. et al. Intestinal microbial communities associated with acute enteric infections and disease recovery. Microbiome3, 45 (2015).
Forbes, J. D. et al. A comparative study of the gut microbiota in immune-mediated inflammatory diseases—does a common dysbiosis exist? Microbiome6, 221 (2018).
Kemter, A. M. & Nagler, C. R. Influences on allergic mechanisms through gut, lung, and skin microbiome exposures. J. Clin. Invest.130, 1483–1492 (2019).
Arrieta, M. C. et al. Associations between infant fungal and bacterial dysbiosis and childhood atopic wheeze in a nonindustrialized setting. J. Allergy Clin. Immunol.142, 424–434 (2018).
Zhai, S. et al. Dietary butyrate suppresses inflammation through modulating gut microbiota in high-fat diet-fed mice. FEMS Microbiol. Lett.366, fnz153 (2019).
Kepert, I. et al. d-Tryptophan from probiotic bacteria influences the gut microbiome and allergic airway disease. J. Allergy Clin. Immunol.139, 1525–1535 (2017).
Cait, A. et al. Reduced genetic potential for butyrate fermentation in the gut microbiome of infants who develop allergic sensitization. J. Allergy Clin. Immunol.144, 1638–1647 (2019).
Bonaz, B., Bazin, T. & Pellissier, S. The vagus nerve at the interface of the microbiota–gut–brain axis. Front. Neurosci.12, 49 (2018).
Osadchiy, V., Martin, C. R. & Mayer, E. A. The gut–brain axis and the microbiome: mechanisms and clinical implications. Clin. Gastroenterol. Hepatol.17, 322–332 (2019).
Kabata, H. & Artis, D. Neuro-immune crosstalk and allergic inflammation. J. Clin. Invest.130, 1475–1482 (2019).
von Mutius, E., Schmid, S. & Group, P. S. The PASTURE project: EU support for the improvement of knowledge about risk factors and preventive factors for atopy in Europe. Allergy61, 407–413 (2006).
Loss, G. et al. Consumption of unprocessed cow’s milk protects infants from common respiratory infections. J. Allergy Clin. Immunol.135, 56–62 (2015).
Loss, G. J. et al. The early development of wheeze. Environmental determinants and genetic susceptibility at 17q21. Am. J. Respir. Crit. Care Med.193, 889–897 (2016).
Hose, A. J. et al. Latent class analysis reveals clinically relevant atopy phenotypes in 2 birth cohorts. J. Allergy Clin. Immunol.139, 1935–1945 (2017).
Fuchs, O. et al. Farming environments and childhood atopy, wheeze, lung function, and exhaled nitric oxide. J. Allergy Clin. Immunol.130, 382–388 (2012).
Roduit, C. et al. Increased food diversity in the first year of life is inversely associated with allergic diseases. J. Allergy Clin. Immunol.133, 1056–1064 (2014).
Depner, M. et al. Atopic sensitization in the first year of life. J. Allergy Clin. Immunol.131, 781–788 (2013).
Bokulich, N. A., Thorngate, J. H., Richardson, P. M. & Mills, D. A. Microbial biogeography of wine grapes is conditioned by cultivar, vintage, and climate. Proc. Natl Acad. Sci. USA111, E139–E148 (2014).
Caporaso, J. G. et al. Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. Proc. Natl Acad. Sci. USA108(Suppl. 1), 4516–4522 (2011).
Bokulich, N. A. & Mills, D. A. Improved selection of internal transcribed spacer-specific primers enables quantitative, ultra-high-throughput profiling of fungal communities. Appl. Environ. Microbiol.79, 2519–2526 (2013).
Caporaso, J. G. et al. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods7, 335–336 (2010).
Callahan, B. J. et al. DADA2: high-resolution sample inference from Illumina amplicon data. Nat. Methods13, 581–583 (2016).
Bokulich, N. A. et al. Optimizing taxonomic classification of marker-gene amplicon sequences with QIIME 2’s q2-feature-classifier plugin. Microbiome6, 90 (2018).
Pedregosa, F. et al. Scikit-learn: machine learning in Python. J. Mach. Learn. Res.12, 2825–2830 (2011).
McDonald, D. et al. An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea. ISME J.6, 610–618 (2012).
Abarenkov, K. et al. The UNITE database for molecular identification of fungi—recent updates and future perspectives. N. Phytol.186, 281–285 (2010).
Kormann, M. S. et al. G-protein-coupled receptor polymorphisms are associated with asthma in a large German population. Am. J. Respir. Crit. Care Med.171, 1358–1362 (2005).
Moffatt, M. F. et al. A large-scale, consortium-based genomewide association study of asthma. N. Engl. J. Med.363, 1211–1221 (2010).
Moffatt, M. F. et al. Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma. Nature448, 470–473 (2007).
Torgerson, D. G. et al. Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations. Nat. Genet.43, 887–892 (2011).
Bouzigon, E. et al. Effect of 17q21 variants and smoking exposure in early-onset asthma. N. Engl. J. Med.359, 1985–1994 (2008).
Caliskan, M. et al. Rhinovirus wheezing illness and genetic risk of childhood-onset asthma. N. Engl. J. Med. 368, 1398–1407 (2013).
Schedel, M. et al. Polymorphisms related to ORMDL3 are associated with asthma susceptibility, alterations in transcriptional regulation of ORMDL3, and changes in TH2 cytokine levels. J. Allergy Clin. Immunol.136, 893–903 (2015).
Dostal, A. et al. Effects of iron supplementation on dominant bacterial groups in the gut, faecal SCFA and gut inflammation: a randomised, placebo-controlled intervention trial in South African children. Br. J. Nutr.112, 547–556 (2014).
Pham, V. T., Lacroix, C., Braegger, C. P. & Chassard, C. Early colonization of functional groups of microbes in the infant gut. Environ. Microbiol.18, 2246–2258 (2016).
Ramirez-Farias, C. et al. Effect of inulin on the human gut microbiota: stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii. Br. J. Nutr.101, 541–550 (2009).
Muthén, L. K. & Muthén, B. O. Mplus User’s Guide 7th edn (Muthén & Muthén, 1998–2012).
Holmes, I., Harris, K. & Quince, C. Dirichlet multinomial mixtures: generative models for microbial metagenomics. PloS ONE7, e30126 (2012).
Breiman, L. Random forests. Mach. Learn.45, 5–32 (2001).
Aitchison, J. The statistical analysis of compositional data. J. Royal Stat. Soc. B44, 139–177 (1982).
Gloor, G. B., Macklaim, J. M., Pawlowsky-Glahn, V. & Egozcue, J. J. Microbiome datasets are compositional: and this is not optional. Front. Microbiol.8, 2224 (2017).
Friedman, J. & Alm, E. J. Inferring correlation networks from genomic survey data. PLoS Comput. Biol.8, e1002687 (2012).
Brandes, U. et al. On modularity clustering. IEEE Trans. Knowl. Data Eng.20, 172–188 (2008).
Langfelder, P. & Horvath, S. Eigengene networks for studying the relationships between co-expression modules. BMC Syst. Biol.1, 54 (2007).
This paper is dedicated to Jean-Charles Dalphin, one of the founders of the PASTURE study, who passed away shortly after the submission of this manuscript. We are very grateful for his constant support of this successful collaboration. We thank B. Stecher and A.-L. Boulesteix for valuable input in discussions about biological and statistical issues, respectively. We are grateful to G. Pagani for technical support with graphs. The PASTURE study was supported by the European Commission (research grants QLK4-CT-2001-00250, FOOD-CT-2006-31708 and KBBE-2007-2-2-06) and the European Research Council (grant 250268). The current analyses were supported by the German Federal Ministry of Education and Research (BMBF; project German Center for Lung Research (DZL)). P.L. and F.M.F. receive funding from the Scottish Government’s Rural and Environment Sciences and Analytical Services Division (RESAS).
D.A.M. is a co-founder of Evolve Biosystems, a company focused on diet-based manipulation of the gut microbiota, and BCD Biosciences, a company advancing novel bioactive glycans. Neither Evolve Biosystems nor BCD Biosciences had a role in the conceptualization, design, data collection, analysis or preparation of this paper. M.K. has a patent share on the diagnostic use of SNPs in ORMDL3 on chromosome 17q21. H.R. has received research support from DFG, BMBF, EU, Land Hessen, DAAD, ALK, Stiftung Pathobiochemie, Ernst-Wendt-Stiftung, Mead Johnson Nutritional and Beckman Coulter; speaker’s honoraria from Allergopharma, Novartis, Thermo Fisher, Danone, Mead Johnson Nutritional and Bencard; and consulting fees from Bencard and Sterna Biologicals. He is a cofounder of Sterna Biologicals. E.v.M. is listed as an inventor on the following patents: publication number EP 1411977, composition containing bacterial antigens used for the prophylaxis and treatment of allergic diseases, granted on 18 April 2007; publication number EP 1637147, stable dust extract for allergy protection, granted on 10 December 2008; publication number EP 1964570, pharmaceutical compound to protect against allergies and inflammatory diseases, granted on 21 November 2012. E.v.M. is listed as an inventor and has received royalties on the following patent: publication number EP 2361632, specific environmental bacteria for the protection from and/or treatment of allergic, chronic inflammatory and/or autoimmune disorders, granted on 19 March 2014. She has received funding and research support from FrieslandCampina; she has received consultation and speaker fees from OM Pharma, Böhringer Ingelheim International, Peptinnovate, Pharmaventures, Nestlé Deutschland (36 months before publication) and HiPP (future). M.J.E. is a co-inventor on patents for the use of environmental bacteria to prevent asthma (EP000001964570B1, US000009950017B2 and EP000002361632B1). His employer has received investigational products for an intervention study with minimally processed milk from FrieslandCampina.
Peer review information Alison Farrell was the primary editor on this article and managed its editorial process and peer review in collaboration with the rest of the editorial team.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The current microbiome analysis population (n = 720) was selected based on available microbiome data at month 12. The French arm was not included because by design microbiome samples were not taken at month 2. The children with samples available at month 2 and 12 (n = 618) were quite equally distributed over the centers (Austria N = 139; Switzerland N = 205; Germany N = 136; Finland N = 138). For n = 102 children only 12 months samples were available. Subsamples are colored in red, blue, and white according to asthma status (yes, no, not available, respectively). The different subsamples colored in grey represent the basis of the respective figures of the main manuscript as indicated*. Samples with fungi data are a subsample of the 618 samples with bacteria, and only children with ITS samples at both time points available were analyzed**. Healthy controls were defined by no diarrhea between 2 and 12 months and no asthma / wheeze anytime; individuals with missing or implausible values for sampling time point were excluded (5 for bacteria, 1 for fungi)***. Butyryl-CoA:acetate CoA-transferase gene assay failed in 19 of the 157 samples (12%) for technical reasons.
a, Scatter plot of the first two axes of a principal coordinate analysis (PCoA) over both time points on ASV (amplicon sequence variants) levels. The values in brackets represent percentage of variance explained after correction of negative eigenvalues. b, Scatterplot of the first PCoA-axis against EMA. c,d, Associations of asthma phenotypes with EMA restricted to individuals not included when establishing the prediction model (n = 480 children), that is the 618 children with measurements at both time points minus the 138 healthy individuals. EMA is used as z-standardized continuous variable (c) and dichotomized at the lowest quartile (d).
Extended Data Fig. 3 Association of principal component axes of microbial composition at 2 and 12 months with asthma phenotypes and bacterial genera.
a, Associations of asthma phenotypes with the first five axes of a principle component analysis (PCA) at month 2. b, Correlation of the asthma-protective PCA-axis 3 at month 2 (7% variance explained) with single genera. c, Associations of asthma phenotypes with PCA-axes at month 12. d, Correlation of the asthma-protective PCA-axis 1 at month 12 (14% variance explained) with single genera. e–g, Mutually adjusted associations of EMA and the asthma-protective axes at both time points with asthma (e), atopic asthma (f), and non-atopic asthma (g). Associations are shown as odds ratios for the z-standardized variables.
Extended Data Fig. 4 Association of principle coordinate axes of microbial composition at 2 and 12 months with asthma phenotypes and bacterial genera.
Associations of asthma phenotypes of the first five axes of a principle coordinate analysis (PCoA) at month 2 a, and 12 c, using unweighted UniFrac as distance measure. Spearman correlations of the 10 most positively and 10 most negatively correlated individual genera with the asthma-protective PCoA-axes at month 2 b, and 12 d. Mutually adjusted models for EMA and the asthma-protective PCoA-axes at month 2 and 12 for asthma e, atopic asthma f, and nonatopic asthma g. Associations are shown as odds ratios for the z-standardized variables.
Extended Data Fig. 5 Correlation of estimated microbiome age (EMA) with asthma-protective axes and richness.
Relationship between EMA (x-axis) and various microbial measures (y-axis) including asthma-protective PCA- a, and PCoA-axes b, and bacterial richness c. The left column relates to 2 months, the right column to 12 months. As correlation coefficient Spearman’s rho is given.
Beta estimates of linear regression model of EMA versus duration of breastfeeding dichotomized at the indicated time points.
The upper panels a, refer to propionate, the lower panels b, to acetate. The left column gives proportion of asthma cases within quartiles of the respective short-chain fatty acid (SCFA) variables. The right column gives odds ratios with 95%-confidence intervals for the associations of asthma phenotypes with the respective dichotomous SCFA variables (upper quartiles versus lowest quartile). Propionate and acetate level designate measured SCFA levels, whereas the estimated scores refer to the prediction models of measured SCFA levels by the microbial composition.
a, Log-scaled box and whiskers plots of relative abundance of most common fungal taxa at month 2 and month 12 in 189 children. Lower and upper hinges of the boxes denote the first and third quartiles, respectively; the bold central line represents the median; the whiskers extend to the most extreme data point within 1.5 times the interquartile range from the hinges; extreme values lie beyond the whiskers and are marked by circles. Missing boxes indicate relative abundance < 0.5% at the respective time point. ‘(F)’, ‘(O)’, or ‘(P)’ stand for unclassified genera of the respective fungal family, order or phylum. b, Chronological age, that is the exact sampling time point in months plotted against estimated fungal age (EFA) illustrates that all chronologic information is largely removed from EFA. The density plot included in panel b reveals a skewed distribution of EFA. c, Fungal taxa most importantly predicting fungal age in the 35 healthy individuals. d, Determinants of EFA in the population with ITS data. Odds ratios are given with 95%-confidence intervals. Listed are determinants with p-values <0.01 in bivariate analyses; only consumption of any bread (shaded in gray) remains in a multivariable model. e, Associations of asthma phenotypes with EFA.
Asthma was defined as a doctor’s diagnosis of asthma or recurrent obstructive bronchitis. Asthma after 3 years was defined as a doctor’s diagnosis of asthma or recurrent obstructive bronchitis after the age of 3 years. The atopic and nonatopic phenotypes of asthma were defined by presence or absence of concomitant sensitization to inhalant allergens with specific IgE ≥ 0.7 IU/ml at age 6 years. Wheeze phenotypes were defined by a latent class analysis as previously performed14. Transient and intermediate wheeze were milder forms with better lung function and less medication. Persistent wheeze was related to genetic risk encoded on chromosome 17q21 and displayed reduced lung function. Lateonset wheeze was particularly associated with atopic sensitization and fraction of exhaled nitric oxide. Seasonal IgE was defined as at least one specific IgE to alder, birch, hazel, grass pollen, rye, mugwort, plantain, or alternaria ≥ 0.7 IU/ml at age 6 years. Perennial IgE (D. pteronyssinus, D. farinae, cat, horse, or dog) and food IgE (hen’s egg, cow’s milk, peanut, hazelnut, carrot or wheat flour) were defined in analogy.
PCA=principal component analysis, EMA=estimated microbiome age, EFA=estimated fungal age; p-values are derived from two-sided Kruskal-Wallis tests. The analyses were performed in all 618 individuals with data available for the respective measures, except for EFA, where data was available only in 189 individuals. Lower and upper hinges of the boxes denote the first and third quartiles, respectively; the bold central line represents the median; the whiskers extend to the most extreme data point within 1.5 times the interquartile range from the hinges; extreme values lie beyond the whiskers and are marked by circles.
About this article
Cite this article
Depner, M., Taft, D.H., Kirjavainen, P.V. et al. Maturation of the gut microbiome during the first year of life contributes to the protective farm effect on childhood asthma. Nat Med 26, 1766–1775 (2020). https://doi.org/10.1038/s41591-020-1095-x
This article is cited by
Environmental Exposures may Hold the Key; Impact of Air Pollution, Greenness, and Rural/Farm Lifestyle on Allergic Outcomes
Current Allergy and Asthma Reports (2023)
Donor age and body weight determine the effects of fecal microbiota transplantation on growth performance, and fecal microbiota development in recipient pigs
Journal of Animal Science and Biotechnology (2022)
Nature Communications (2022)
Impact of Volatile and Semi-volatile Organic Compounds from Farming Environments on Allergy-Related Cellular Processes
Exposure and Health (2022)